MedTrace Logo

Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease

NCT06760650 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2025-01-07

No results posted yet for this study

Summary

Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence of acute kidney injury induced by fluorescein in diabetic patients with CKD. The objective is to determine the incidence, severity and risk factors associated with this deterioration to improve the care of this specific population.

Conditions

Interventions

DIAGNOSTIC_TEST

Fluorescein angiography

Fluorescein angiography

Sponsors & Collaborators

  • Saint-Joseph University

    lead OTHER

Principal Investigators

  • Mabel AOUN, M.D., M.P.H. · Faculty of Medicine, Saint Joseph University of Beirut

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-07
Primary Completion
2025-10-10
Completion
2025-10-10

Countries

  • Lebanon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06760650 on ClinicalTrials.gov